Article

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

2020-03-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f355cce8-2aba-5279-ad4e-4e83113b7ee4
DOI: 10.1016/j.ccell.2020.03.003

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 ActivityDOI 10.1016/j.ccell.2020.03.003Read

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 ActivitySemantic proximity Read

Poziotinib for uncommon ERBB mutations.Semantic proximity Read

NAMPT: A critical driver and therapeutic target for cancerSemantic proximity Read

Mechanism of activation and the rewired network: New drug design concepts.Semantic proximity Read

ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasmsSemantic proximity Read

An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations.Semantic proximity Read

Recurrent FBXW7 mutations bypass Wnt/β-catenin addiction in cancerSemantic proximity Read

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid NeoplasmsSemantic proximity Read

WNT-driven chromosomal instability as a biomarker for PORCN inhibitionSemantic proximity Read

Members of FOX family could be drug targets of cancersSemantic proximity Read

Network Pharmacology-Based Prediction of Anticancer Targets of Mebendazole: Integrating Molecular Targets, Signaling Pathways, and Clinical EvidenceSemantic proximity Read

Development of a pipeline to evaluate YAP-TEAD inhibitor potential - direct TEAD inhibition represses cancerous growth in a NF2 -mutant model of mesotheliomaSemantic proximity Read